New Frontiers in Vitiligo Treatment: Dr. Chau Yee Ng Presents Real-World Evidence on JAK Inhibitors and Future Trends

 
The 51st Annual Meeting of the Taiwanese Dermatological Association (TDA) has successfully concluded. We are proud to announce that our Center Director, Dr. Chau Yee Ng, MD, PhD, was invited to co-chair the "Pigmentary Disorders Session" alongside Professor Cheng-Che Lan from Kaohsiung Medical University. The session featured distinguished international experts, including Prof. Itefat Hamzavi (USA), Prof. Marwa Abdallah (Egypt), and Prof. Jung Min Bae (Korea), facilitating a high-level exchange on the latest advancements in vitiligo management.

 
Presenting Local Data on JAK Inhibitors

Addressing the latest therapeutic innovations, Dr. Ng presented the team's research on the "Real-world Experience of Topical JAK Inhibitors in Taiwanese Vitiligo Patients." The presentation analyzed clinical data from nearly 100 local patients, evaluating the efficacy and safety profile of these FDA-approved agents specifically for Taiwanese skin types. Dr. Ng also discussed future trends, including oral JAK inhibitors and novel biologics. This significant contribution provides essential local evidence to guide clinical decision-making in Taiwan.

Research Excellence by Our Medical Team

The Center’s residents demonstrated outstanding academic capabilities with the following presentations:

• Dr. Hsin-Yu Shih presented a 10-year follow-up study of over 900 patients, analyzing the long-term stability of vitiligo under various treatment modalities, including systemic therapy, phototherapy, topical agents, and combination approaches.

• Dr. Sheng-Ni Chen reported on the safety of aesthetic and laser procedures in patients with vitiligo, offering vital safety guidelines for practitioners.

  
Fostering International Collaboration and Cultural Exchange

Beyond the scientific sessions, Dr. Ng hosted the international guests on a cultural tour of Taipei, visiting landmarks such as the National Palace Museum, Dihua Street, and Liberty Square. Special thanks are extended to Chief Resident Dr. Po-Chien Wu and Dr. Hsin-Yu Shih for their assistance in making this event a success.

Our Center remains committed to advancing the treatment of vitiligo and pigmentary disorders, bridging international expertise with local clinical excellence to provide the best possible care for our patients.